Study of MAR001 in Adults With Metabolic Dysfunction

Clinical trial NCT05896254 · COMPLETED

Trial details

NCT number: NCT05896254
Sponsor: Marea Therapeutics
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hypertriglyceridemia

Start date: 2023-07-22
Primary completion: 2024-12-13
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.